Mode
Text Size
Log in / Sign up
N/A N=15 Randomized Single-blind Treatment

Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment

Depression

Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcome: Primary: Adherence to Antidepressant Medication — 0; 0; 0; 1 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
MedLink System (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Northwestern University
Primary completion
Apr 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Adherence to Antidepressant Medication
0; 0; 0; 1; 0; 1
SECONDARY
Patient Health Questionnaire-9 (PHQ-9)
15.25; 11.43; 10.57; 5.57; 5.80; 3.43

Summary

The goal of this project is to develop and pilot a mobile smartphone delivered intervention that will improve antidepressant medication care by providing medication adherence monitoring and support to the patient, feedback on patient adherence and response to treatment to the primary care team, and information to both patients and providers on guideline-congruent care personalized to the patient's response to antidepressant medication.

Eligibility Criteria

Inclusion Criteria

  • Has been prescribed an antidepressant medication by a Primary Care Provider, but has not yet initiated treatment
  • Has depression determined by primary care physician
  • Is familiar with the use of mobile phones
  • Is able and willing to carry the mobile phone
  • Is able to speak and read English
  • Is at least 18 years of age

Exclusion Criteria

  • Is current taking an antidepressant medication or has taken one in the previous 3 months
  • Has visual, hearing, voice, or motor impairment that would prevent completion of study procedures or use of mobile phone
  • Is diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current substance dependence, or other diagnosis for which participation in this trial is either inappropriate or dangerous. Patients with substance dependence diagnoses who have been clean and sober for 12 months will be admitted if otherwise eligible
  • Is severely suicidal (has ideation, plan, and intent)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01909973). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search